All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Stacofylline | NCIT_C74224 | |
| Lung Cancer pM1a TNM Finding v7 | NCIT_C88880 | [Lung cancer with separate tumor nodule(s) in a contralateral lobe; tumor with pleural nodules or malignant pleural (or pericardial) effusion. Most pleural (and pericardial) effusions with lung cancer are due to tumor. In a few patients, however, multiple cytopathologic examinations of pleural (or pericardial) fluid) are negative for tumor, and the fluid is nonbloody and is not an exudate. Where these elements and clinical judgment dictate that the effusion is not related to the tumor, the effusion should be excluded as a staging element and the patient should be classified as M0. (from AJCC 7th Ed.)] |
| Lung Cancer pM1b TNM Finding v7 | NCIT_C88881 | [Distant metastasis. (from AJCC 7th Ed.)] |
| Lung Cancer Clinical TNM Finding v7 | NCIT_C88882 | [A clinical finding about one or more characteristics of lung cancer, following the rules of the TNM AJCC v7 classification system. The clinical classification is based on the evidence acquired before treatment, including physical examination, imaging studies, laboratory tests, and staging procedures such as bronchoscopy or esophagoscopy with ultrasound directed biopsies, mediastinoscopy, mediastinotomy, thoracentesis, and thoracoscopy as well as exploratory thoracotomy. (from AJCC 7th Ed.)] |
| Lung Cancer TNM Finding v7 | NCIT_C88865 | [A finding about one or more characteristics of lung cancer, following the rules of the TNM AJCC v7 classification system. This classification is used for both non-small cell and small cell lung carcinomas and for carcinoid tumors of the lung. Sarcomas and other rare tumors of the lung are not included. (from AJCC 7th Ed.)] |
| Aganodine | NCIT_C74229 | |
| Lung Cancer pT1 TNM Finding v7 | NCIT_C88868 | [Lung cancer with a tumor size of 3 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a. (from AJCC 7th Ed.)] |
| Lung Cancer pT1a TNM Finding v7 | NCIT_C88869 | [Lung cancer with a tumor size of 2 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a. (from AJCC 7th Ed.)] |
| Ocular Adnexal Lymphoma cM1b TNM Finding v7 | NCIT_C88862 | [Lymphomatous involvement of the bone marrow. (from AJCC 7th Ed.)] |
| Ocular Adnexal Lymphoma cM1c TNM Finding v7 | NCIT_C88863 | [Both M1a and M1b involvement. (from AJCC 7th Ed.)] |
| Flubanilate | NCIT_C74240 | |
| Almitrine | NCIT_C74241 | |
| Sulmarin | NCIT_C74242 | |
| Etryptamine Acetate | NCIT_C74236 | |
| Monoamine Oxidase Inhibitor | NCIT_C667 | [Any substance that inhibits monoamine oxidase (MAO), an enzyme that catalyzes the oxidative deamination of monoamines and plays a role in the inactivation of neurotransmitters.] |
| Amfetaminil | NCIT_C74237 | |
| Amiphenazole | NCIT_C74238 | |
| Pyritinol | NCIT_C74239 | |
| Azintamide | NCIT_C74232 | |
| Florantyrone | NCIT_C74233 |